A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors

NCT06990698 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: FP008 for injection

Sponsor

Zhuhai Fapon Biopharma Co., Ltd.